Now showing items 1-3 of 3

    • Parra Soto, Solange Liliana; Cowley, Emma S.; Rezende, Leandro F. M.; Ferreccio Keadi, Catterina; Mathers, John C.; Pell, Jill P.; Ho, Frederick K.; Celis Morales, Carlos (BMC, 2021)
      Background: Adiposity is a strong risk factor for cancer incidence and mortality. However, most of the evidence available has focused on body mass index (BMI) as a marker of adiposity. There is limited evidence on ...
    • Díaz Vegas, Alexis; Sánchez Aguilera, Pablo; Krycer, James R; Morales, Pablo E.; Monsalves Álvarez, Matías; Cifuentes Koster, Mariana; Rothermel, Beverly A.; Lavandero González, Sergio (Endocrine Society, 2020)
      Mitochondrial damage is implicated as a major contributing factor for a number of noncommunicable chronic diseases such as cardiovascular diseases, cancer, obesity, and insulin resistance/type 2 diabetes. Here, we discuss ...
    • Lorca, Marcos; Morales Verdejo, César; Vásquez Velásquez, David; Andrades Lagos, Juan Andrés; Campanini Salinas, Javier; Soto Delgado, Jorge; Recabarren Gajardo, Gonzalo; Mella, Jaime (MDPI, 2018)
      The wide tissue distribution of the adrenergic 3 receptor makes it a potential target for the treatment of multiple pathologies such as diabetes, obesity, depression, overactive bladder (OAB), and cancer. Currently, there ...